Navigation Links
Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Date:2/2/2010

SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) announced today that it will present at the 12th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2010 at 10:00 a.m. EST (7:00 a.m. PST).  The conference is being held at the Waldorf-Astoria Hotel in New York.  Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will provide an overview of Anadys and its clinical development programs, ANA598 and ANA773.

Additionally, Dr. Worland will participate as a panelist on the BIO CEO & Investor Conference HCV Panel on Tuesday, February 9, 2010 at 12:00 p.m. EST (9:00 a.m. PST).

The corporate presentation will be simultaneously webcast and can be accessed on the Investor Relations page of the Company's website at www.anadyspharma.com.  Listeners are encouraged to visit the website approximately five minutes prior to the corporate presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the live webcast concludes and will be available through February 23, 2010.

About Anadys

Anadys Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for th
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference
2. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
3. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
5. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
6. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
7. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
8. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
9. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
10. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
11. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 ... are artificial implants used to replace, augment, or ... in a wide range of applications including cosmetic, ... implants are made of different materials such as ... forecast the global implantable medical devices market to ...
(Date:9/2/2015)... -- The quantum dot market report analyzes the ecosystem of ... the product includes medical devices, display, and others. The others ... energy storage, QD laser, and transistor. The application segment covers ... market. The report also provides the geographic view for major ... Europe , Asia-Pacific (APAC), ...
(Date:9/2/2015)... Sept. 2, 2015  Array BioPharma Inc. (Nasdaq: ... Executive Officer, Ron Squarer , will present ... Boston.  The public is welcome to participate in ... BioPharma website.Event: Wells Fargo Securities Healthcare ConferencePresenter: Ron ... 2015Time:  , 10:20 a.m. Eastern Time Webcast: ...
Breaking Medicine Technology:Global Implantable Medical Devices Market 2015-2019 2Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2
... CVS/pharmacy introduced an updated mobile app that allows ... eliminating the need to carry an ExtraCare card when shopping. ... program with more than 69 million active cardholders, and the ... simply scan the barcode on the back of their card ...
... 1, 2012  Techne Corporation,s (NASDAQ: TECH ) ... ended March 31, 2012 include the following highlights: ... per diluted share.  Adjusted earnings for the quarter were ... of 5.9% from the same prior-year period. Adjusted earnings ...
Cached Medicine Technology:CVS/pharmacy Mobile App Transforms Smartphones into Digital ExtraCare Cards 2Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 2Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 3Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 4Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 5Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 6Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 7Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 8Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 9Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 10Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results 11
(Date:9/2/2015)... Los Angeles, CA (PRWEB) , ... September 02, 2015 , ... ... entry featured by the Huffington Post on August 25th, writer Akela Stanfield detailed ... bariatric surgery. While the author acknowledged that she had always seen herself as someone ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... swamped with a large stream of mixed documents that include EOBs, payments, and ... documents, while extracting the data needed to reconcile their billing, with one efficient ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... Sciences clinical and academic partnership has earned international recognition as a premier center ... disorder that can cause sudden, catastrophic internal bleeding and stroke. , Cure ...
(Date:9/2/2015)... ... September 02, 2015 , ... Medical ... has completed a recapitalization with new investment partners Beecken Petty O’Keefe & ... each offer extensive expertise and connections within the healthcare industry, which makes ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Amada Senior Care, ... office in Kansas – its Johnson County location. Amada franchise partners Mike ... has a registered nurse background and spent over 20 years in medical device sales ...
Breaking Medicine News(10 mins):Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:AliusDoc Launches Enhanced AD-EOB A/R Data Capture Solution to Streamline Processing of Payment-Related Documents Together with EOBs 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:Amada Senior Care Expands to Greater Kansas City 2
... Healthcare,Corporation (Nasdaq: UAHC ), which owns and ... organization in,Tennessee, today announced financial results for its ... increased 82 percent to $8.3 million for the ... revenues of $4.6 million for,the third quarter of ...
... MOUNTAIN VIEW, Calif., May 13 IRIDEX,Corporation (Nasdaq: IRIX ... ended March 29, 2008., Revenue for the first quarter ... million reported for the first quarter of 2007. The,Company,s net ... the,first quarter of 2008 compared with a net loss of ...
... for, Potential 2008 Launch of MOXATAG; Keflex Product Sales Total $2.4 ... ... GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ... today,announced financial and operational results for the quarter ended March 31,2008., ...
... that treat the poor from improving, study finds , , TUESDAY, ... hospitals that treat poor and underserved patients, often called safety-net ... these patients, a new study finds. , These hospitals, which ... sources, do not have the money to improve the quality ...
... to treat a rare but well-known genetic disorder may hold ... potentially lethal enlarged hearts, due mainly to high blood pressure, ... common denominator in both phenylketonuria (PKU) and cardiac hypertrophy is ... helps break down the molecule phenylalanine whose buildup is toxic ...
... BLOOMFIELD HILLS, Mich., May 13 CJPS Enterprises, ... be holding a,half-day mini-seminar and interactive discussions about ... to increase their,competitiveness, and therefore their worth. This ... June 6th, 2008 and is applicable to both ...
Cached Medicine News:Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 2Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 3Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 4Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 5Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 6Health News:United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results 7Health News:IRIDEX Reports First Quarter 2008 Financial Results 2Health News:IRIDEX Reports First Quarter 2008 Financial Results 3Health News:IRIDEX Reports First Quarter 2008 Financial Results 4Health News:IRIDEX Reports First Quarter 2008 Financial Results 5Health News:IRIDEX Reports First Quarter 2008 Financial Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 2Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 3Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 4Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 5Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 6Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 7Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 8Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 9Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 10Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 11Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 12Health News:MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results 13Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2
... technology is here! LTF™ (Layered Thin Film) ... test platform that is easy to read, ... as a credit card. What is Infectious ... reason women visit their physician. Vaginal discharge ...
... test! QuickScreen multi-panel dip cards offer minimal ... choice of any conceivable combination of 9 ... for your drug testing program. Just dip ... built-in timer tells you when to read ...
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
Medicine Products: